Elizabeth Schwarzbach

San Mateo, California, United States
Elizabeth Schwarzbach has over 20 years of experience in biopharma and academia drug discovery and development. She found her passion for pharmacology as a biologist in Merck Research Labs, later completing her doctorate in neuropharmacology at the University of Pennsylvania School of Medicine. After gaining growth, portfolio, and investment strategy experience at L.E.K. Consulting’s Life Sciences practice, she transitioned to GlaxoSmithKline R&D Strategy team. She has served in strategy and business development leadership roles at Axovant, Sanford Burnham Prebys Medical Discovery Insitute, and the New York Stem Cell Foundation (NYSCF) Research Institute, Currently, Elizabeth is the Cheif Business Officer at BigHat Biosciences.
Speaking In
3:00 PM - 4:00 PM (PDT)
Tuesday, June 14
Partnerships between pharma and biotech hit record levels in 2021 both in terms of deals volume and…